Immix (IMMX) Sof foyda bo'yicha sotuv rentabelligi

Immix Biopharma Inc. (IMMX) tovar belgisi

CAR-T dori ishlab chiqarishda nuqsonlarni minimallashtirish uchun laboratoriyani avtomatlashtirish Immix Biopharma, Inc. (IMMX) biznesini mustahkamlaydi, buni GURU.Markets grafigidagi sof foyda marjasi tasdiqlaydi, u yerda 0.00 qiymati metrika darajasini ifodalaydi. Aktiv mielomaga qarshi NXC-201 terapiyasining global joriy etilishiga tayanadi, kelajakdagi daromadlar esa sug'urta kompaniyalari orqali saraton bemorlari uchun shaxsiylashtirilgan mahsulotlarni yetkazib berishga asoslangan.

IMMX: immixbio.com Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Immix Biopharma, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Immix - IMMX
immixbio.com yetakchi tovari

Immix Biopharma, Inc. (IMMX) qattiq o'smalarga qarshi kurashish uchun shaxsiy dori yetkazib berish usullariga investitsiya kiritmoqda. Foyda marjasi barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin jami daromadning sof foyda ulushini o'lchaydi. Ushbu ko'rsatkich biznesning daromadsiz holatga o'tishini real vaqt rejimida baholash imkonini beradi. Investorlar ushbu koeffitsient orqali intellektual aktivlarni monetizatsiya qilish samaradorligini baholaydilar. Kompaniyaning tijorat foyda marjasini tahlil qilish orqali pozitsiyaning xavf profilini o'z vaqtida sozlash mumkin.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi pyxisoncology.com|Sof marja cgen.com (CGEN)|IOBT: Sof foyda marjasi|Sutro Biopharma Inc. - Sof foyda bo'yicha sotuv rentabelligi|minktherapeutics.com (INKT) - Sof marja|HOWL: Sof foyda bo'yicha sotuv rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)